nSTRIDE Autologous Protein Solution (APS) Kit

Zimmer Biomet Announces Positive Results from PROGRESS II Trial of Autologous Protein Solution Prepared with nSTRIDE® APS Kit

WARSAW, Ind., Dec. 22, 2017 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced…